![Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2dd4dc19-c81b-434c-80ab-b33c1d1b342a/gr2_lrg.jpg)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet
![Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality - ScienceDirect Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870303003247-gr1.gif)
Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality - ScienceDirect
![Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2000988592/2003637687/gr1.gif)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet
![Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design](https://scielo.isciii.es/img/revistas/ejpen/v30n1/original02_figura1.jpg)
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
![ACTIV-4a: A Multicenter, Adaptive, Randomized, Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 | PETAL Network ACTIV-4a: A Multicenter, Adaptive, Randomized, Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 | PETAL Network](https://petalnet.org/sites/default/files/public-study-logos/Screen%20Shot%202021-06-17%20at%201.09.37%20PM.png)